Takeo Ohsugi

1.1k total citations
54 papers, 788 citations indexed

About

Takeo Ohsugi is a scholar working on Immunology, Agronomy and Crop Science and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Takeo Ohsugi has authored 54 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 26 papers in Agronomy and Crop Science and 24 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Takeo Ohsugi's work include T-cell and Retrovirus Studies (35 papers), Animal Disease Management and Epidemiology (26 papers) and Vector-Borne Animal Diseases (24 papers). Takeo Ohsugi is often cited by papers focused on T-cell and Retrovirus Studies (35 papers), Animal Disease Management and Epidemiology (26 papers) and Vector-Borne Animal Diseases (24 papers). Takeo Ohsugi collaborates with scholars based in Japan, United States and United Kingdom. Takeo Ohsugi's co-authors include Toshio Kumasaka, Toshiki Watanabe, Takaomi Ishida, Kazuo Umezawa, Toru Urano, Seiji Okada, Takashi Kurosawa, Kazunari Yamaguchi, Atsushi Koito and Ryouichi Horie and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Takeo Ohsugi

53 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeo Ohsugi Japan 17 323 282 171 168 91 54 788
Kunli Zhang China 16 219 0.7× 205 0.7× 87 0.5× 45 0.3× 107 1.2× 33 575
Xiaodong Wu China 14 84 0.3× 198 0.7× 61 0.4× 52 0.3× 91 1.0× 37 549
Aad Hoek Netherlands 18 424 1.3× 196 0.7× 122 0.7× 32 0.2× 298 3.3× 37 1.1k
Lin Zhan China 15 138 0.4× 261 0.9× 32 0.2× 47 0.3× 96 1.1× 38 791
Huijun Guo China 16 186 0.6× 232 0.8× 33 0.2× 41 0.2× 198 2.2× 103 803
Paweł Zmora Poland 16 117 0.4× 200 0.7× 251 1.5× 41 0.2× 171 1.9× 36 956
Rolf Rauh United States 14 38 0.1× 254 0.9× 140 0.8× 90 0.5× 78 0.9× 19 797
Tien‐Jye Chang Taiwan 16 67 0.2× 287 1.0× 38 0.2× 27 0.2× 206 2.3× 42 972
Xiaolan Yu China 17 89 0.3× 366 1.3× 90 0.5× 14 0.1× 194 2.1× 35 711

Countries citing papers authored by Takeo Ohsugi

Since Specialization
Citations

This map shows the geographic impact of Takeo Ohsugi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Ohsugi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Ohsugi more than expected).

Fields of papers citing papers by Takeo Ohsugi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Ohsugi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Ohsugi. The network helps show where Takeo Ohsugi may publish in the future.

Co-authorship network of co-authors of Takeo Ohsugi

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Ohsugi. A scholar is included among the top collaborators of Takeo Ohsugi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Ohsugi. Takeo Ohsugi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monde, Kazuaki, Ryoko Koga, Takeo Ohsugi, et al.. (2023). The unique activity of saponin: Induction of cytotoxicity in HTLV-1 infected cells. Bioorganic & Medicinal Chemistry. 91. 117408–117408. 1 indexed citations
2.
Kozako, Tomohiro, et al.. (2023). AICAR Induces AMPK-Independent Cell Death in Adult T-Cell Leukemia/Lymphoma and Has Anti-Tumor Activity. Blood. 142(Supplement 1). 7146–7146. 1 indexed citations
3.
Kozako, Tomohiro, Takeo Ohsugi, Yuichiro Uchida, et al.. (2023). CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma. Biological and Pharmaceutical Bulletin. 46(9). 1269–1276. 4 indexed citations
4.
Kozako, Tomohiro, et al.. (2023). Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia/lymphoma. European Journal of Pharmacology. 961. 176180–176180. 4 indexed citations
5.
Ali, Taha F. S., Halil I. Ciftci, Mohamed O. Radwan, et al.. (2019). New SIRT2 inhibitors: Histidine-based bleomycin spin-off. Bioorganic & Medicinal Chemistry. 27(9). 1767–1775. 17 indexed citations
6.
Kozako, Tomohiro, Takeo Ohsugi, Yuichiro Uchida, et al.. (2019). High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor. European Journal of Pharmacology. 865. 172738–172738. 23 indexed citations
7.
Ohsugi, Takeo. (2013). A transgenic mouse model of human T cell leukemia virus type 1-associated diseases. Frontiers in Microbiology. 4. 49–49. 15 indexed citations
8.
Ohsugi, Takeo, Kumi Matsuura, Naoko Nakamura, et al.. (2013). Natural infection of murine norovirus in conventional and specific pathogen-free laboratory mice. Frontiers in Microbiology. 4. 12–12. 21 indexed citations
9.
Ohsugi, Takeo & Toshio Kumasaka. (2011). Low CD4/CD8 T-Cell Ratio Associated with Inflammatory Arthropathy in Human T-Cell Leukemia Virus Type I Tax Transgenic Mice. PLoS ONE. 6(4). e18518–e18518. 23 indexed citations
11.
Ikeda, Terumasa, Takeo Ohsugi, Tetsuya Kimura, et al.. (2008). The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Research. 36(21). 6859–6871. 37 indexed citations
12.
Ohsugi, Takeo & Atsushi Koito. (2008). Current Topics in Prevention of Human T-Cell Leukemia Virus Type I Infection: NF-κ B Inhibitors and APOBEC3. International Reviews of Immunology. 27(4). 225–253. 5 indexed citations
13.
Fu, Yingmei, Fengmin Zhang, Wenli Zhang, et al.. (2007). Differential expression of blaSHV related to susceptibility to ampicillin in Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 29(3). 344–347. 27 indexed citations
14.
Ohsugi, Takeo, Toshio Kumasaka, Seiji Okada, et al.. (2007). Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with Tax-deficient adult T-cell leukemia-derived cell lines. Cancer Letters. 257(2). 206–215. 23 indexed citations
15.
Ohsugi, Takeo, Ryouichi Horie, Toshio Kumasaka, et al.. (2005). In vivo antitumor activity of the NF-κB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia. Carcinogenesis. 26(8). 1382–1388. 53 indexed citations
16.
Ohsugi, Takeo, Toshio Kumasaka, Akira Ishida, et al.. (2005). In vitro and in vivo antitumor activity of the NF-κB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102. Leukemia Research. 30(1). 90–97. 34 indexed citations
17.
Ohsugi, Takeo. (2005). Activation of a cryptic splice site in the tax gene of HTLV-I by a single nucleotide change. Biochimie. 88(2). 147–150. 2 indexed citations
18.
Ohsugi, Takeo, Kazunari Yamaguchi, Toshio Kumasaka, et al.. (2004). Rapid tumor death model for evaluation of new therapeutic agents for adult T-cell leukemia. Laboratory Investigation. 84(2). 263–266. 9 indexed citations
19.
Ohsugi, Takeo, et al.. (1996). HTLV-I Infections in Offspring Derived from HTLV-I Carrier Rats during the Suckling Period.. The Kurume Medical Journal. 43(1). 1–9. 1 indexed citations
20.
Ohsugi, Takeo, et al.. (1994). Engraftment of HTLV-I-Transformed Human T-Cell Line into SCID Mice with NK Cell Function.. Journal of Veterinary Medical Science. 56(3). 601–603. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026